Immunome (IMNM) earnings, Nov 9, 2026: EPS +1%, stock +3.5%
In brief
Immunome reported on Nov 9, 2026. Earnings per share changed +1% year over year, 3.4% below the estimate; revenue −100%. The stock opened with a +0.1% gap and closed the day +3.5% (Nov 9, 2026). The stock is now 35.6% below its 52-week high, +27.0% over 12 months. Next report: Mar 25, 2027.
EPS vs estimate−3.4%
EPS, YoY+1%
Revenue, YoY−100%
Gap · day+0.1% · +3.5%
EPS growth by quarter, YoY
Price reaction to earnings
| Report | Gap | Day |
|---|---|---|
| May 12, 2026 | +3.1% | −2.2% |
| Aug 11, 2026 | −3.9% | +6.6% |
| Nov 9, 2026 | +0.1% | +3.5% |
Next-quarter estimates, ratings and the IMNM chart are in the terminal.
Open the terminalFAQ
When is Immunome's next earnings report?
Mar 25, 2027. The date comes from daily data and is corrected if the company moves it.
How did Immunome stock react to the report?
Opening gap +0.1%, day's result +3.5%.
Did Immunome's earnings grow?
Earnings per share rose 1% year over year.
What is an earnings gap?
The jump between the close before and the open after the report. A big gap up often means large buyers are revaluing the company.